(Q40730929)

23 September 2017

title

A phase II study of interleukin-2 and interferon-alpha in head and neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428731

25 September 2022

author name string

S. P. Schantz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428731

25 September 2022

I. Dimery

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428731

25 September 2022

S. M. Lippman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428731

25 September 2022

G. L. Clayman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428731

25 September 2022

C. Pellegrino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428731

25 September 2022

R. Morice

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1428731

25 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1428731

25 September 2022

publication date

1 August 1992

1 reference

Investigational New Drugs

23 September 2017

published in

1 reference

23 September 2017

volume

10

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

217-223

1 reference

Oncogene amplification in squamous cell carcinoma of the oral cavity.

23 September 2017

cites work

1 reference

12 December 2020

Lymphocyte phenotypes at tumor margins in patients with head and neck cancer

1 reference

12 December 2020

Natural killer cell activity and head and neck cancer: a clinical assessment

1 reference

12 December 2020

Interferon therapy in cancer: from imaginon to interferon.

1 reference

12 December 2020

Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.

1 reference

12 December 2020

Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer

1 reference

12 December 2020

Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.

1 reference

12 December 2020

Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.

1 reference

12 December 2020

Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial

1 reference

12 December 2020

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer

1 reference

12 December 2020

In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy

1 reference

12 December 2020

Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer

1 reference

12 December 2020

The in vivo biologic effect of interleukin 2 and interferon alfa on natural immunity in patients with head and neck cancer

1 reference

12 December 2020

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

12 December 2020

Interleukin-2: inception, impact, and implications

1 reference

12 December 2020

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study

1 reference

12 December 2020

Reactivity of lymphocytes from normal persons on cultured tumor cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00877250

1 reference

Dimensions Publication ID

23 September 2017

1048697821

0 references

1 reference